Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Capricor Therapeutics (CAPR) Receivables - Net: 2015-2024

Historic Receivables - Net for Capricor Therapeutics (CAPR) over the last 1 years, with Dec 2024 value amounting to $10.0 million.

  • Capricor Therapeutics' Receivables - Net changed negligibly% to $10.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $10.0 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $10.0 million for FY2024, which is negligibly% changed negligibly from last year.
  • As of Q4 2024, Capricor Therapeutics' Receivables - Net stood at $10.0 million, which was down 0.00% from $10.0 million recorded in Q4 2023.
  • Capricor Therapeutics' Receivables - Net's 5-year high stood at $10.0 million during Q4 2023, with a 5-year trough of $10.0 million in Q4 2023.
  • Over the past 2 years, Capricor Therapeutics' median Receivables - Net value was $10.0 million (recorded in 2024), while the average stood at $10.0 million.